Log in
Register- Biogenerics / India Ravi Telkar 2011-09-13 13:26
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- ANVISA guideline pash413 2011-08-01 13:35
- ANVISA guideline suds4u 2011-08-02 05:29
- ANVISA guideline rams.stat 2011-09-09 13:40
- Guidelines for Taiwan vishal 2011-08-29 15:02
- Guidelines for Taiwan yjlee168 2011-08-29 19:12
- Guidelines for Taiwan vishal 2011-08-30 07:29
- Guidelines for Taiwan yjlee168 2011-08-31 00:50
- Guidelines for Taiwan vishal 2011-09-03 07:18
- Guidelines for Taiwan yjlee168 2011-08-31 00:50
- Guidelines for Taiwan vishal 2011-08-30 07:29
- Guidelines for Taiwan yjlee168 2011-08-29 19:12
- Validity of DCGI BE NOC for Drug Products for BE studies taresh41 2011-05-11 08:28
- Validity of DCGI BE NOC for Drug Products for BE studies swapnil.kuche 2011-06-08 06:38
- Validity of DCGI BE NOC for Drug Products for BE studies vishal 2011-08-29 15:12
- Validity of DCGI BE NOC for Drug Products for BE studies swapnil.kuche 2011-06-08 06:38
- Exclusion of subject from the calculation of AUCinf ratnakar1811 2011-08-03 07:21
- Exclusion of subject from the calculation of AUCinf Helmut 2011-08-03 13:55
- Exclusion of subject from the calculation of AUCinf ratnakar1811 2011-08-04 08:51
- Exclusion of subject from the calculation of AUCinf Helmut 2011-08-04 11:09
- Exclusion of subject from the calculation of AUCinf ratnakar1811 2011-08-04 14:58
- Exclusion of subject from the calculation of AUCinf Helmut 2011-08-05 10:38
- Exclusion of subject from the calculation of AUCinf ratnakar1811 2011-08-06 09:34
- Exclusion of subject from the calculation of AUCinf Helmut 2011-08-05 10:38
- Exclusion of subject from the calculation of AUCinf ratnakar1811 2011-08-04 14:58
- Exclusion of subject from the calculation of AUCinf Helmut 2011-08-04 11:09
- Exclusion of subject from the calculation of AUCinf ratnakar1811 2011-08-04 08:51
- Exclusion of subject from the calculation of AUCinf Helmut 2011-08-03 13:55
- IVIVC swapnil.kuche 2011-08-04 09:22
- IVIVC swapnil.kuche 2011-08-05 10:41
- Politeness Helmut 2011-08-05 10:51
- Politeness swapnil.kuche 2011-08-05 11:01
- Politeness Helmut 2011-08-05 10:51
- IVIVC yjlee168 2011-08-05 14:35
- IVIVC swapnil.kuche 2011-08-05 10:41
- EMA guideline on method validation published Ohlbe 2011-08-02 13:04
- overview of comments Helmut 2011-08-02 16:59
- Acarbose Study Design for US filing hiren379 2011-07-30 17:11
- measurement of active metabolite in european submission suchit_bhavsar 2011-07-26 13:49
- If possible, parent only Helmut 2011-07-26 14:23
- Evaluation of BE Parameters swapnil.kuche 2011-07-19 11:24
- Evaluation of BE Metrics Helmut 2011-07-19 19:21
- Clinical Trials Requirement for NDDS swapnil.kuche 2011-07-19 11:19
- Clinical Trials Requirement for NDDS ElMaestro 2011-07-19 11:50
- Clinical Trials Requirement for NDDS swapnil.kuche 2011-07-19 12:06
- Clinical Trials Requirement for NDDS ElMaestro 2011-07-19 13:02
- Clinical Trials Requirement for NDDS swapnil.kuche 2011-07-19 12:06
- Clinical Trials Requirement for NDDS ElMaestro 2011-07-19 11:50
- delegation responsibilities for a study Varsha 2011-07-18 10:46
- Regulation of IECs suchit_bhavsar 2011-07-18 07:59
- Regulation of Indian IECs Helmut 2011-07-18 10:29
- RLD for TGA Market Hemant7613 2011-07-05 09:06
- RLD for TGA Market Helmut 2011-07-06 09:36
- Endogenous Cmax 2011-07-03 09:01
- Sensitivity to detect differences of endogenous compounds Helmut 2011-07-03 11:23
Ing. Helmut Schütz